1 / 6

Point of Care Testing Market Trends Information and Competitive Landscape Scenario to 2026

Point of Care Testing Market Trends Information and Competitive Landscape Scenario to 2026

vinayakshinde
Download Presentation

Point of Care Testing Market Trends Information and Competitive Landscape Scenario to 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Point of Care Testing Market 2020-2026 | Growth Forecast & Industry Share Report • Point of care testing (POC) market is poised to witness tremendous growth over the projected timeframe of 2020 to 2026. This can be credited to increased popularity of point of care testing as an advanced healthcare solution. Rising prevalence of chronic diseases across the globe and growing awareness regarding early disease diagnosis have also led to increased adoption of POC testing. According to the World Cancer Report, prevalence of cancer is expected to increase by nearly 50% accounting for more than 15 million new cases of cancer in 2020. According to Global Market Insights, Inc. report, point of care testing market size is projected to surpass USD 39.1 billion and is expected to show a significant growth rate of 7.1% through 2026. • With regards to the product spectrum, drug of abuse (DoA) testing segment held an appreciable market share of 9.2% in the past and is projected to grow over time owing to numerous advantages endowed by this testing such as qualitative data and quick results. © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  2. In terms of application, infectious disease testing segment is estimated to register a notable growth rate of 7.3% through 2026 with a valuation of USD 2.9 billion. This can be attributed to the significance of point of care tests in improving detection and management of infectious diseases by reducing the time between infection testing and diagnosis. Moreover, benefits of point of care testing such as faster diagnosis, which provides the patients with timely access to treatment and care, will instigate application of point of care testing for infectious disease testing over the foreseeable future. • In terms of end-use, research laboratories segment is anticipated to show enormous growth over the upcoming years on account of rising application of point of care testing for cancer marker devices. In this regard, increasing research activities for developing diagnostic tests for early detection of cancerous tumors will open new growth avenues for the industry. Moreover, market players are also partnering with research laboratories for developing sophisticated point of care tests for enhancing their product offerings which will complement the segment growth significantly. For the record, in 2019, the segment accounted for a sizeable market share of 11.9%. • Speaking of the technology landscape, immunoassays segment accounted for a valuation of USD 4.4 billion in 2019 and is likely to experience steady growth during subsequent years. The growth can be credited to increased usage of rapid immunoassays at point of care facilities such as emergency rooms, student health clinics and labor and delivery suites for improving quality of care © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  3. Request for a Sample Copy of this Report @ https://www.gminsights.com/request-sample/detail/3086 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  4. Regional Analysis • Asia Pacific point of care testing industry is projected to observe substantial growth rate of 8.7% over the analysis timeframe owing to rising incidence of infectious diseases and increasing investment in healthcare by government. For instance, as per Avert.org report, in 2019, around 5.8 million residents in Asia Pacific were diagnosed with HIV infection. This has urged government to focus on early diagnosis and mitigation of such infectious diseases which will have a positive impact on the industry growth. Further, growing demand for point of care diagnostic tests across hospitals and laboratories for emergency and critical care, particularly for influenza, will contribute to the regional growth. • Competitive Analysis • Prominent industry players operating in point of testing care market such as Abbott, Bio-Rad Laboratories, BioMerieux, Siemens Healthineers, Trinity Biotech, OraSure Technologies, Sysmex Corporation, etc. are focusing on novel product launches, mergers, acquisitions, geographical expansion in order to gain strong market presence. For instance, in 2017, Abbott announced acquisition of Alere, one of the renowned point-of-care diagnostics companies. © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  5. Latest Research Report On Point of Care Testing Market @ https://www.gminsights.com/industry-analysis/point-of-care-testing-market Request for sample of this research report@ https://www.gminsights.com/request-sample/detail/3086 Request for customization: https://www.gminsights.com/roc/3086 © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com

  6. Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2017 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com www.gminsights.com

More Related